Gastrointestinal Diseases  >>  mizagliflozin (VGX-3235)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mizagliflozin (VGX-3235) / Vogenx
NCT01600001: A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

Completed
2
75
Japan
KWA-0711, Placebo
Kissei Pharmaceutical Co., Ltd.
Chronic Idiopathic Constipation
 
 
NCT01937663: A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation

Completed
2
Japan
KWA-0711
Kissei Pharmaceutical Co., Ltd.
Chronic Constipation
01/14
 
NCT01938196: A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation

Completed
2
Japan
KWA-0711, Placebo
Kissei Pharmaceutical Co., Ltd.
Chronic Constipation
01/14
 

Download Options